Cansu Baris Mogul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cansu Baris Mogul has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Emre Özmen
Department of Cardiology, Kanuni Sultan Süleyman Training and Research Hospital, Health Science University, İstanbul 34303, Türkiye
1 shared publication - Furkan Ufuk
Department of Radiology, University of Chicago, Chicago, USA
1 shared publication Gulsah Gundogdu
Department of Physiology, Faculty of Medicine, Pamukkale University, Denizli, Turkey
1 shared publication- Harun Akarsu
Department of Cardiology, Pamukkale University, Denizli, Turkey
1 shared publication - Ismail Dogu Kilic
Department of Cardiology, Pamukkale University, Denizli, Turkey
1 shared publication İpEk Büber
Department of Cardiology, Pamukkale University, Denizli, Turkey
1 shared publication
Latest Publications
- 8 October 2026
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 62 (5) , 1760-1773
Protective Effects of Caffeic Acid against Alternate-Day Fasting-Induced Hepatic Oxidative Toxicity in Rats: Modulation of the Glutathione Redox Axis and SOD Expression
Alternate-day fasting (ADF) is widely utilized for metabolic regulation. But its potential to trigger hepatic oxidative stress and perturb redox-sensitive gene expression warrants toxicological evaluation. In this study, we investigated the protective effects of caffeic acid (CA) against ADF-induced hepatic oxidative toxicity and lipid metabolism disorders, focusing on its modulatory role in the glutathione redox axis and superoxide dismutase (SOD) expression. Twenty-eight male Sprague–Dawley rats were assigned to four groups: Control, ADF (24-h cycles for 6 weeks), CA (50 mg/kg/day), and ADF+CA. Enzymatic antioxidant levels of SOD, catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), lipid parameters (total cholesterol, triglycerides) were assessed by ELISA The total antioxidant status (TAS) and total oxidant status (TOS) were analysed using commercial kits and oxidative stress index (OSI) was calculated accordingly. Hepatic mRNA expression of SOD1, SOD2, and SOD3 was quantified by qRT-PCR. ADF significantly reduced hepatic CAT levels and elevated TOS levels relative to control, and significantly increased total cholesterol relative to the ADF+CA group, indicating ADF-induced oxidative and lipid stress. CA co-administration significantly restored SOD and GR levels in the ADF+CA group compared with the ADF, CA, and control groups, and significantly increased GPx and GR relative to ADF alone, while also normalizing cholesterol levels. At the transcriptional level, SOD1, SOD2, and SOD3 mRNA expression showed a numerical downregulation trend under ADF and the most pronounced numerical upregulation in the ADF+CA group (up to 3.10-fold for SOD1), although these differences did not reach statistical significance. Together, these findings indicate that prolonged ADF induces hepatic oxidative stress and disrupts lipid homeostasis, and that CA supplementation confers hepatoprotection primarily by restoring antioxidant enzyme activity and the glutathione redox axis, with a supportive but statistically non-significant trend toward increased SOD gene expression. Prolonged alternate-day fasting (ADF) induces severe hepatic oxidative stress (increased ROS) and hyperlipidemia alongside the transcriptional downregulation of SOD1, SOD2, and SOD3 isoforms. Concurrently, Caffeic Acid (CA) treatment acts as a potent genetic and enzymatic regulator, normalizing cholesterol and triglyceride levels, upregulating SOD family mRNA expression, and reinforcing the hepatic GR-GPx glutathione cycle.
- 8 October 2026
- Published by Pleiades Publishing Ltd in Journal of Evolutionary Biochemistry and Physiology
- Vol. 62 (5) , 1760-1773
Protective Effects of Caffeic Acid against Alternate-Day Fasting-Induced Hepatic Oxidative Toxicity in Rats: Modulation of the Glutathione Redox Axis and SOD Expression
Alternate-day fasting (ADF) is widely utilized for metabolic regulation. But its potential to trigger hepatic oxidative stress and perturb redox-sensitive gene expression warrants toxicological evaluation. In this study, we investigated the protective effects of caffeic acid (CA) against ADF-induced hepatic oxidative toxicity and lipid metabolism disorders, focusing on its modulatory role in the glutathione redox axis and superoxide dismutase (SOD) expression. Twenty-eight male Sprague–Dawley rats were assigned to four groups: Control, ADF (24-h cycles for 6 weeks), CA (50 mg/kg/day), and ADF+CA. Enzymatic antioxidant levels of SOD, catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), lipid parameters (total cholesterol, triglycerides) were assessed by ELISA The total antioxidant status (TAS) and total oxidant status (TOS) were analysed using commercial kits and oxidative stress index (OSI) was calculated accordingly. Hepatic mRNA expression of SOD1, SOD2, and SOD3 was quantified by qRT-PCR. ADF significantly reduced hepatic CAT levels and elevated TOS levels relative to control, and significantly increased total cholesterol relative to the ADF+CA group, indicating ADF-induced oxidative and lipid stress. CA co-administration significantly restored SOD and GR levels in the ADF+CA group compared with the ADF, CA, and control groups, and significantly increased GPx and GR relative to ADF alone, while also normalizing cholesterol levels. At the transcriptional level, SOD1, SOD2, and SOD3 mRNA expression showed a numerical downregulation trend under ADF and the most pronounced numerical upregulation in the ADF+CA group (up to 3.10-fold for SOD1), although these differences did not reach statistical significance. Together, these findings indicate that prolonged ADF induces hepatic oxidative stress and disrupts lipid homeostasis, and that CA supplementation confers hepatoprotection primarily by restoring antioxidant enzyme activity and the glutathione redox axis, with a supportive but statistically non-significant trend toward increased SOD gene expression. Prolonged alternate-day fasting (ADF) induces severe hepatic oxidative stress (increased ROS) and hyperlipidemia alongside the transcriptional downregulation of SOD1, SOD2, and SOD3 isoforms. Concurrently, Caffeic Acid (CA) treatment acts as a potent genetic and enzymatic regulator, normalizing cholesterol and triglyceride levels, upregulating SOD family mRNA expression, and reinforcing the hepatic GR-GPx glutathione cycle.
- 14 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4368-4377
Differential Biventricular Strain Recovery With Selective Fibrosis Biomarker Regression After Sleeve Gastrectomy: A Prospective CMR Feature-Tracking Study
Purpose Obesity injures the heart through hemodynamic, fibrotic, and adipokine pathways, but whether these reverse together or on different timelines after bariatric surgery is unknown. We performed, to our knowledge, the first integrated assessment of biventricular and biatrial cardiovascular magnetic resonance feature-tracking (CMR-FT), fibrosis and adipokine biomarkers, cardiovascular risk, and quality of life after laparoscopic sleeve gastrectomy (LSG), testing whether recovery is uniform or uneven. Materials and Methods In this single-center prospective cohort, 40 patients underwent LSG; 8 were lost to follow-up, leaving 32 (28 with paired CMR; 26 women; aged 36.3 ± 7.6 years; baseline BMI 41.1 ± 4.8 kg/m²) studied before and a median 8.4 months after surgery. Results Left ventricular mass declined from 93.3 to 78.9 g (p < 0.001), alongside improved LVGLS (16.0 to 18.6%, p = 0.003), MAPSE (p = 0.004), and LVEF (p = 0.021). RVEF increased (p = 0.013) without parallel change in RVGLS or TAPSE. Left atrial volume index was unchanged, with only a reservoir-strain trend toward improvement (p = 0.059). Only galectin-3 and endotrophin declined (both p < 0.001); FABP4, apelin, and adiponectin were unchanged. NT-proBNP rose (p < 0.001) despite falling blood pressure and improving strain. Metabolic risk factors improved broadly; Framingham risk and all SF-36 domains improved (p < 0.001). Conclusion Cardiac reverse remodeling after LSG is measurable but uneven within the first year. LV longitudinal mechanics improved alongside mass regression, whereas RVEF rose without parallel longitudinal change, consistent with afterload reduction rather than intrinsic RV recovery. Fibrosis-linked galectin-3 and endotrophin declined while adipokines remained static, indicating distinct fibrotic and adipokine timelines. The components that respond earliest are those that conventional preoperative assessment overlooks. Graphical Abstract
- 14 July 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (8) , 4368-4377
Differential Biventricular Strain Recovery With Selective Fibrosis Biomarker Regression After Sleeve Gastrectomy: A Prospective CMR Feature-Tracking Study
Purpose Obesity injures the heart through hemodynamic, fibrotic, and adipokine pathways, but whether these reverse together or on different timelines after bariatric surgery is unknown. We performed, to our knowledge, the first integrated assessment of biventricular and biatrial cardiovascular magnetic resonance feature-tracking (CMR-FT), fibrosis and adipokine biomarkers, cardiovascular risk, and quality of life after laparoscopic sleeve gastrectomy (LSG), testing whether recovery is uniform or uneven. Materials and Methods In this single-center prospective cohort, 40 patients underwent LSG; 8 were lost to follow-up, leaving 32 (28 with paired CMR; 26 women; aged 36.3 ± 7.6 years; baseline BMI 41.1 ± 4.8 kg/m²) studied before and a median 8.4 months after surgery. Results Left ventricular mass declined from 93.3 to 78.9 g (p < 0.001), alongside improved LVGLS (16.0 to 18.6%, p = 0.003), MAPSE (p = 0.004), and LVEF (p = 0.021). RVEF increased (p = 0.013) without parallel change in RVGLS or TAPSE. Left atrial volume index was unchanged, with only a reservoir-strain trend toward improvement (p = 0.059). Only galectin-3 and endotrophin declined (both p < 0.001); FABP4, apelin, and adiponectin were unchanged. NT-proBNP rose (p < 0.001) despite falling blood pressure and improving strain. Metabolic risk factors improved broadly; Framingham risk and all SF-36 domains improved (p < 0.001). Conclusion Cardiac reverse remodeling after LSG is measurable but uneven within the first year. LV longitudinal mechanics improved alongside mass regression, whereas RVEF rose without parallel longitudinal change, consistent with afterload reduction rather than intrinsic RV recovery. Fibrosis-linked galectin-3 and endotrophin declined while adipokines remained static, indicating distinct fibrotic and adipokine timelines. The components that respond earliest are those that conventional preoperative assessment overlooks. Graphical Abstract